ATE504566T1 - Zur behandlung von auf eine modulation des dopamin-d3-rezeptors ansprechende erkrankungen geeignete heterocyclische verbindungen - Google Patents

Zur behandlung von auf eine modulation des dopamin-d3-rezeptors ansprechende erkrankungen geeignete heterocyclische verbindungen

Info

Publication number: ATE504566T1
Authority: AT; Austria
Prior art keywords: alkyl; fluorinated; treatment; cycloalkyl; dopamine
Prior art date: 2004-10-14

Application number

AT05805167T

Other languages

English (en)

Inventor

Karla Drescher

Andreas Haupt

Liliane Unger

Sean Turner

Wilfried Braje

Roland Grandel

Christophe Henry

Gisela Backfisch

Armin Beyerbach

Wilfried Lubisch

Original Assignee

Abbott Gmbh & Co Kg

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-10-14

Filing date

2005-10-14

Publication date

2011-04-15

2005-10-14 Application filed by Abbott Gmbh & Co Kg filed Critical Abbott Gmbh & Co Kg

2011-04-15 Application granted granted Critical

2011-04-15 Publication of ATE504566T1 publication Critical patent/ATE504566T1/de

Links

102000004073 Dopamine D3 Receptors Human genes 0.000 title abstract 2
108090000525 Dopamine D3 Receptors Proteins 0.000 title abstract 2
201000010099 disease Diseases 0.000 title 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
150000002391 heterocyclic compounds Chemical class 0.000 title 1
125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 abstract 3
229910052799 carbon Inorganic materials 0.000 abstract 3
125000005842 heteroatom Chemical group 0.000 abstract 3
229910052739 hydrogen Inorganic materials 0.000 abstract 3
150000001875 compounds Chemical class 0.000 abstract 2
125000000623 heterocyclic group Chemical group 0.000 abstract 2
125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
229910052760 oxygen Inorganic materials 0.000 abstract 2
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
150000003839 salts Chemical class 0.000 abstract 2
SNOOUWRIMMFWNE-UHFFFAOYSA-M sodium;6-[(3,4,5-trimethoxybenzoyl)amino]hexanoate Chemical compound [Na+].COC1=CC(C(=O)NCCCCCC([O-])=O)=CC(OC)=C1OC SNOOUWRIMMFWNE-UHFFFAOYSA-M 0.000 abstract 2
125000001424 substituent group Chemical group 0.000 abstract 2
229910052717 sulfur Inorganic materials 0.000 abstract 2
125000001054 5 membered carbocyclic group Chemical group 0.000 abstract 1
125000004008 6 membered carbocyclic group Chemical group 0.000 abstract 1
125000006577 C1-C6 hydroxyalkyl group Chemical group 0.000 abstract 1
125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 abstract 1
125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 abstract 1
125000002485 formyl group Chemical group [H]C(*)=O 0.000 abstract 1
229910052736 halogen Inorganic materials 0.000 abstract 1
150000002367 halogens Chemical class 0.000 abstract 1
239000003446 ligand Substances 0.000 abstract 1
125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 abstract 1
125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 abstract 1
125000005550 pyrazinylene group Chemical group 0.000 abstract 1
125000005551 pyridylene group Chemical group 0.000 abstract 1
-1 pyrimidylene Chemical group 0.000 abstract 1
229920006395 saturated elastomer Polymers 0.000 abstract 1
125000005730 thiophenylene group Chemical group 0.000 abstract 1
125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
- C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
- C07D211/28—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms to which a second hetero atom is attached
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Psychology (AREA)
Pain & Pain Management (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Pyrrole Compounds (AREA)

AT05805167T 2004-10-14 2005-10-14 Zur behandlung von auf eine modulation des dopamin-d3-rezeptors ansprechende erkrankungen geeignete heterocyclische verbindungen ATE504566T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US61887804P	2004-10-14	2004-10-14
PCT/EP2005/011106 WO2006040182A1 (en)	2004-10-14	2005-10-14	Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor

Publications (1)

Publication Number	Publication Date
ATE504566T1 true ATE504566T1 (de)	2011-04-15

Family

ID=35744845

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT05805167T ATE504566T1 (de)	2004-10-14	2005-10-14	Zur behandlung von auf eine modulation des dopamin-d3-rezeptors ansprechende erkrankungen geeignete heterocyclische verbindungen

Country Status (17)

Country	Link
US (2)	US7851463B2 (de)
EP (3)	EP2311803A1 (de)
JP (1)	JP4904277B2 (de)
KR (1)	KR101315192B1 (de)
CN (1)	CN101039904B (de)
AT (1)	ATE504566T1 (de)
AU (1)	AU2005293698B2 (de)
BR (1)	BRPI0515998A (de)
CA (1)	CA2583983C (de)
DE (1)	DE602005027382D1 (de)
ES (1)	ES2364488T3 (de)
IL (1)	IL182431A (de)
MX (1)	MX2007004359A (de)
NZ (1)	NZ555123A (de)
TW (1)	TWI364414B (de)
WO (1)	WO2006040182A1 (de)
ZA (1)	ZA200703061B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20040204422A1 (en)	2003-04-14	2004-10-14	Abbott Gmbh & Co. Kg.	N-[(Piperazinyl)hetaryl]arylsulfonamide compounds
US7851463B2 (en) *	2004-10-14	2010-12-14	Abbott Gmbh & Co. Kg	Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
WO2007021941A2 (en) *	2005-08-16	2007-02-22	Icagen, Inc.	Inhibitors of voltage-gated sodium channels
TW200808762A (en)	2006-04-19	2008-02-16	Abbott Gmbh & Co Kg	Heterocyclic compounds suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor
TW200812961A (en)	2006-04-19	2008-03-16	Abbott Gmbh & Co Kg	Heterocyclic compounds suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor
DE102007036068A1 (de)	2007-08-01	2009-02-05	Wacker Chemie Ag	Verfahren zur Herstellung von Alkyl-methoxymethyl-trimethylsilanylmethylaminen
DE102008022221A1 (de)	2008-05-06	2009-11-12	Universität des Saarlandes	Inhibitoren der humanen Aldosteronsynthase CYP11B2
US8541404B2 (en)	2009-11-09	2013-09-24	Elexopharm Gmbh	Inhibitors of the human aldosterone synthase CYP11B2
CN102276511A (zh) *	2011-06-20	2011-12-14	兰州博实生化科技有限责任公司	1-叔丁氧羰基-3-碘氮杂环丁烷的合成方法
EP3233799B1 (de)	2014-12-19	2021-05-19	The Broad Institute, Inc.	Dopamin-d2-rezeptor-liganden
EP3233077B1 (de)	2014-12-19	2026-05-06	The Broad Institute, Inc.	Dopamin-d2-rezeptor-liganden
CN109503449A (zh) *	2018-12-17	2019-03-22	天津药明康德新药开发有限公司	一种3-硝基吖丁啶-1-甲酸叔丁酯的合成方法
KR20260083444A (ko)	2019-11-25	2026-06-05	알케르메스,인코포레이티드	치환된 마크로사이클릭 화합물 및 관련 치료 방법
US11760747B2 (en)	2020-12-21	2023-09-19	Alkermes, Inc.	Substituted piperidino compounds and related methods of treatment
JP7833486B2 (ja)	2021-05-26	2026-03-19	アルカーメス，インコーポレイテッド	置換されるカルバメート大環状化合物および関連のある治療方法
JP2025521508A (ja) *	2022-06-21	2025-07-10	アルカームスインコーポレーテッド	置換ピロリジニル及びピペリジニル化合物並びに関連する治療方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN85106905A (zh) *	1985-08-08	1987-02-04	Fmc公司	含有1-芳基-δ2-1，2，4，-三唑啉-5-酮类的除草剂及其制备方法
AU5175490A (en)	1989-02-27	1990-09-26	Du Pont Merck Pharmaceutical Company, The	Novel sulfonamides as radiosensitizers
DE4303376A1 (de) *	1993-02-05	1994-08-11	Bayer Ag	Substituierte Triazolinone
FR2703688B1 (fr)	1993-04-09	1995-05-19	Rhone Poulenc Chimie	Réactif de désallylation, procédé de désallylation utilisant ledit réactif.
JPH08511789A (ja) *	1993-06-25	1996-12-10	スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー	フェニルピロール誘導体およびドーパミンｄ３拮抗薬としてのそれらの使用
ES2139750T3 (es)	1993-08-06	2000-02-16	Upjohn Co	2-aminoindanos como ligandos selectivos d3 de la dopamina.
DE4425143A1 (de) *	1994-07-15	1996-01-18	Basf Ag	Substituierte Pyrimidinverbindungen und deren Verwendung
DE19500689A1 (de) *	1995-01-12	1996-07-18	Merck Patent Gmbh	Indolpiperidin-Derivate
WO1996023760A1 (en)	1995-02-01	1996-08-08	Pharmacia & Upjohn Company	2-aminoindans as selective dopamine d3 ligands
EP0909299B1 (de)	1996-05-30	2003-02-19	Baker Hughes Incorporated	Naphtensäurekorrosionskontrolle mit thiophosphorverbindungen
CN1159292C (zh)	1996-05-31	2004-07-28	法玛西雅厄普约翰美国公司	用作选择性多巴胺d3配体的芳基取代的环胺类化合物
DZ2376A1 (fr) *	1996-12-19	2002-12-28	Smithkline Beecham Plc	Dérivés de sulfonamides nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant.
TW450954B (en)	1998-05-14	2001-08-21	Pharmacia & Amp Upjohn Company	Phenylsulfonamide-phenylethylamines useful as dopamine receptors
SK492001A3 (en) *	1998-07-20	2001-08-06	Merck Patent Gmbh	Biphenyl derivatives
DE19922443A1 (de)	1999-05-07	2000-11-09	Basf Ag	Verwendung von Dopamin-D3-Rezeptorliganden zur Herstellung von Arzneimittel für die Behandlung von Nierenfunktionsstörungen
US7851463B2 (en) *	2004-10-14	2010-12-14	Abbott Gmbh & Co. Kg	Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor
TW200812961A (en) *	2006-04-19	2008-03-16	Abbott Gmbh & Co Kg	Heterocyclic compounds suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor

2005
- 2005-10-14 US US11/665,399 patent/US7851463B2/en not_active Expired - Fee Related
- 2005-10-14 EP EP10183342A patent/EP2311803A1/de not_active Withdrawn
- 2005-10-14 CN CN200580035304.0A patent/CN101039904B/zh not_active Expired - Fee Related
- 2005-10-14 DE DE602005027382T patent/DE602005027382D1/de not_active Expired - Lifetime
- 2005-10-14 EP EP05805167A patent/EP1814849B1/de not_active Expired - Lifetime
- 2005-10-14 KR KR1020077010955A patent/KR101315192B1/ko not_active Expired - Fee Related
- 2005-10-14 BR BRPI0515998-9A patent/BRPI0515998A/pt not_active IP Right Cessation
- 2005-10-14 ES ES05805167T patent/ES2364488T3/es not_active Expired - Lifetime
- 2005-10-14 MX MX2007004359A patent/MX2007004359A/es active IP Right Grant
- 2005-10-14 CA CA2583983A patent/CA2583983C/en not_active Expired - Fee Related
- 2005-10-14 JP JP2007536111A patent/JP4904277B2/ja not_active Expired - Fee Related
- 2005-10-14 AU AU2005293698A patent/AU2005293698B2/en not_active Ceased
- 2005-10-14 NZ NZ555123A patent/NZ555123A/en not_active IP Right Cessation
- 2005-10-14 TW TW094136070A patent/TWI364414B/zh not_active IP Right Cessation
- 2005-10-14 WO PCT/EP2005/011106 patent/WO2006040182A1/en not_active Ceased
- 2005-10-14 AT AT05805167T patent/ATE504566T1/de not_active IP Right Cessation
- 2005-10-14 EP EP10183328A patent/EP2311802A1/de not_active Withdrawn
2007
- 2007-04-10 IL IL182431A patent/IL182431A/en not_active IP Right Cessation
- 2007-04-13 ZA ZA200703061A patent/ZA200703061B/xx unknown
2010
- 2010-08-25 US US12/868,480 patent/US8470810B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
CN101039904A (zh)	2007-09-19
US20110160176A1 (en)	2011-06-30
EP2311803A1 (de)	2011-04-20
TW200619195A (en)	2006-06-16
CA2583983A1 (en)	2006-04-20
DE602005027382D1 (de)	2011-05-19
KR20070084208A (ko)	2007-08-24
MX2007004359A (es)	2007-07-17
US7851463B2 (en)	2010-12-14
IL182431A0 (en)	2007-07-24
EP2311802A1 (de)	2011-04-20
BRPI0515998A (pt)	2008-08-19
US20080045493A1 (en)	2008-02-21
EP1814849A1 (de)	2007-08-08
HK1111681A1 (en)	2008-08-15
AU2005293698A1 (en)	2006-04-20
JP4904277B2 (ja)	2012-03-28
TWI364414B (en)	2012-05-21
ES2364488T3 (es)	2011-09-05
NZ555123A (en)	2011-01-28
JP2008516918A (ja)	2008-05-22
WO2006040182A1 (en)	2006-04-20
AU2005293698B2 (en)	2011-12-15
IL182431A (en)	2012-04-30
KR101315192B1 (ko)	2013-10-10
US8470810B2 (en)	2013-06-25
ZA200703061B (en)	2008-09-25
CA2583983C (en)	2013-07-16
EP1814849B1 (de)	2011-04-06
CN101039904B (zh)	2014-09-24

Legal Events

Date	Code	Title	Description
2011-10-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
IL182431A0 (en)	2007-07-24	Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
EA200600317A1 (ru)	2006-06-30	Производные омега-карбоксиарилдифенилмочевины (варианты), фармацевтическая композиция (варианты) и способ лечения и предупреждения заболеваний и состояний с их использованием (варианты)
EA200500304A1 (ru)	2005-10-27	Производные 3-(сульфонамидоэтил)индола, предназначенные для использования в качестве миметиков глюкокортикоидов при лечении воспалительных, аллергических и пролиферативных заболеваний
UA87416C2 (ru)	2009-07-10	Гетероциклические амиды, композиция на их основе и способ борьбы с заражением полезных растений фитопатогенными микроорганизмами и его предупреждение, промежуточные соединения
NO20061406L (no)	2006-08-25	Organiske forbindelser
NO20071138L (no)	2007-02-28	Piperazinderivater som er nyttige for behandling av gastrointestinallidelser
EA201290260A1 (ru)	2013-12-30	Бензимидазол-имидазольные производные
NO20080456L (no)	2008-03-04	Nye 2,4-dianilinopyrimidinderivater, fremstilling derav og deres anvendelse som medikamenter, farmasoytiske sammensetninger og, spesielt, som IKK inhibitorer
RU2011108281A (ru)	2012-09-20	Трипиридилкарбоксамидные антагонисты орексиновых рецепторов
EA200700099A1 (ru)	2007-08-31	Производные пиридина
DK1206484T3 (da)	2005-01-24	Antipicornavirale forbindelser og sammensætninger, deres farmaceutiske anvendelser og materialer til deres syntese
JP2013509392A5 (de)	2013-11-28
NO20055977L (no)	2006-02-16	Nye benzimidazolderivater
MX339143B (es)	2016-05-13	Solvatos y complejos cristalinos de los derivados de (1s)-1,5-anhidro-1-c-(3-((fenil)metil)fenil)-d-glucitol con aminoacidos como inhibidores de sglt2 para el tratamiento de la diabetes.
EA201001407A1 (ru)	2011-06-30	Производные хиноксалинона в качестве стимуляторов секреции инсулина, способы их получения и их применение для лечения диабета
ATE512961T1 (de)	2011-07-15	Amorphes nebivolol hydrochlorid und seine herstellung
AR041298A1 (es)	2005-05-11	Derivados de pirrolidona como inhibidores de maob
RU2006130000A (ru)	2008-02-27	Органические соединения
CN107840845A (zh)	2018-03-27	胺类化合物的新用途
ATE518824T1 (de)	2011-08-15	Substituierte cyclohexylmethyl-derivate
NO20063576L (no)	2006-10-06	1,3-dioksanederivativer og analoge forbindelser for behandling av fedme og diabetes
RU2006138663A (ru)	2008-05-27	Производные пиперидина в качестве модуляторов хемокинового рецептора ccr5
AR071619A1 (es)	2010-06-30	Compuestos de pirazina fusionados utiles para el tratamiento de enfermedades degenerativas e inflamatorias y composiciones farmaceuticas que los contienen.
UY28688A1 (es)	2005-07-29	Derivados de amida
JP2024501995A5 (de)	2024-12-27